Cellular Barcoding Identifies Clonal Substitution as a Hallmark of Local Recurrence in a Surgical Model of Head and Neck Squamous Cell Carcinoma

Cell Rep. 2018 Nov 20;25(8):2208-2222.e7. doi: 10.1016/j.celrep.2018.10.090.

Abstract

Local recurrence after surgery for head and neck squamous cell carcinoma (HNSCC) remains a common event associated with a dismal prognosis. Improving this outcome requires a better understanding of cancer cell populations that expand from postsurgical minimal residual disease (MRD). Therefore, we assessed clonal dynamics in a surgical model of barcoded HNSCC growing in the submental region of immunodeficient mice. Clonal substitution and massive reduction of clonal heterogeneity emerged as hallmarks of local recurrence, as the clones dominating in less heterogeneous recurrences were scarce in their matched primary tumors. These lineages were selected by their ability to persist after surgery and competitively expand from MRD. Clones enriched in recurrences exhibited both private and shared genetic features and likely originated from ancestors shared with clones dominating in primary tumors. They demonstrated high invasiveness and epithelial-to-mesenchymal transition, eventually providing an attractive target for obtaining better local control for these tumors.

Keywords: DNA barcoding; LeGO vectors; RGB marking; clonal heterogeneity; clonal substitution; epithelial-mesenchymal transition; head and neck squamous cell carcinoma; invasion; recurrent tumor-initiating clones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers, Tumor / metabolism
  • Carcinogenesis / pathology
  • Cell Line, Tumor
  • Cell Lineage
  • Cell Proliferation
  • Clone Cells
  • Disease Models, Animal
  • Epithelial-Mesenchymal Transition
  • Female
  • Humans
  • Male
  • Mice, Nude
  • Models, Anatomic*
  • Models, Statistical
  • Neoplasm Recurrence, Local / pathology*
  • Neoplastic Stem Cells / pathology
  • Neprilysin / metabolism
  • Phenotype
  • Squamous Cell Carcinoma of Head and Neck / genetics
  • Squamous Cell Carcinoma of Head and Neck / pathology*
  • Squamous Cell Carcinoma of Head and Neck / surgery*
  • Xenograft Model Antitumor Assays

Substances

  • Biomarkers, Tumor
  • Neprilysin